Profile for Montenegro Patent: 02628
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Montenegro Patent: 02628
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Sep 3, 2029 | Bristol | EVOTAZ | atazanavir sulfate; cobicistat |
| ⤷ Start Trial | Sep 3, 2029 | Janssen Prods | PREZCOBIX | cobicistat; darunavir ethanolate |
| ⤷ Start Trial | Sep 3, 2029 | Janssen Prods | SYMTUZA | cobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
